SCPHARMACEUTICALS INC. Accretion Expense
SCPHARMACEUTICALS INC. reported Accretion Expense of $4.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Operating Expenses
us-gaap:AccretionExpense · last filed 2022-05-16
- SCPHARMACEUTICALS INC. accretion expense for the quarter ending 2022-03-31 was $4.00K, a 94.94% decline year-over-year.
- SCPHARMACEUTICALS INC. accretion expense for the quarter ending 2021-03-31 was $79.00K.
- SCPHARMACEUTICALS INC. accretion expense for fiscal 2021 was $124.00K, a 1.64% increase from fiscal 2020.
- SCPHARMACEUTICALS INC. accretion expense for fiscal 2020 was $122.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 12 month |
|---|---|---|
| 2022-03-31 | $4.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $124.00K 10-K · filed 2022-03-22 | |
| 2021-03-31 | $79.00K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $122.00K 10-K · filed 2022-03-22 |